Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer

A higher density of tumor-infiltrating lymphocytes (TILs) can lead to greater therapeutic effects and improved prognoses in cancer treatment. Similar results have been observed in breast cancer, particularly in triplenegative breast cancer (TNBC) and human epidermal growth factor receptor 2-enriched breast cancer.